![Rick Pollack, American Hospital Association CEO and President standing in front of United States flag and the AHA seal.](/sites/default/files/2022-04/AT-Rick-Pollack-Perspective-2022-News-900x400.jpg)
Johnson & Johnson was notified that the Food and Drug Administration now will require that the company add to the label of its COVID-19 vaccine a warning of a small, increased risk of Guillain-Barré syndrome, a rare but potentially serious neurological condition.